Neuro.Al Algorithm— 510(k) K200750

Name: FDA 510(k) clearance K200750
Creator: U.S. Food and Drug Administration
Published: 2020-11-06

Substantially Equivalent

Terarecon,Inc.

FDA 510(k) clearance K200750 for Neuro.Al Algorithm, Substantially Equivalent on 2020-11-06. Applicant: Terarecon,Inc.. Device class: 2.

Clearance details

Applicant: Terarecon,Inc.
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2020-03-23
Decision date: 2020-11-06
Decision: Substantially Equivalent
Clearance type: Special
Location: Durham, NC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

More clearances from Terarecon,Inc.

view all

K250288 — TeraRecon Cardiovascular.Calcification.CT2025-10-23
K243158 — TeraRecon Aorta.CT (1.1.0)2025-01-23
K241312 — TeraRecon Cardiac.Chambers.MR (1.0.0)2024-11-05
K220349 — TeraRecon Neuro2022-08-12
K191585 — iNtuition-Structural Heart Module2019-07-12

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.